Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print November 17, 2005, 10.1148/radiol.2381041985
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2381041985v1
238/1/87    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Megibow, A. J.
Right arrow Articles by Williams, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Megibow, A. J.
Right arrow Articles by Williams, A. B.
(Radiology 2005;238:87-95.)
© RSNA, 2005


Contrast Media

Evaluation of Bowel Distention and Bowel Wall Appearance by Using Neutral Oral Contrast Agent for Multi–Detector Row CT1

Alec J. Megibow, MD, MPH, James S. Babb, PhD, Elizabeth M. Hecht, MD, Jennie J. Cho, BS, Carmela Houston, MS, CCRA, Michael M. Boruch, AAS, CCRA and Archie B. Williams

1 From the Department of Radiology, New York University School of Medicine, 550 First Ave, Rm IRM 232, New York, NY 10016 (A.J.M., J.S.B., E.M.H., J.J.C.); and E-Z-Em, Lake Success, NY (C.H., M.M.B., A.B.W.). From the 2004 RSNA Annual Meeting. Received November 22, 2004; revision requested January 18, 2005; revision received March 24; accepted April 21. Supported by a grant from E-Z-Em. Address correspondence to A.J.M. (e-mail: alec.megibow{at}nyumc.org).

Purpose: To prospectively evaluate the performance of an orally administered 0.1% barium suspension, Volumen, as a bowel-marking agent for multi–detector row computed tomography (CT).

Materials and Methods: This HIPAA-compliant study was approved by the Institutional Review Board and conformed to the institutional standards for research funded by a commercial sponsor. A total of 60 patients (33 women, 27 men; average age, 58.2 years) who were referred for multi–detector row CT of the pancreas were randomized into two groups. Prior to examination, group 1 consumed 1200 mL of Volumen over a 30-minute period and group 2 consumed 1200 mL of a solution containing three parts water and one part methylcellulose over a 30-minute period. Results were independently reviewed by two radiologists who were unaware of the contrast agent used. The degree of distention and the visualization of mural detail were qualitatively scored on a five-point scale. Differences were evaluated by using the Mann-Whitney test at a confidence level of 95%.

Results: There was significantly better distention in the stomach (P = .013), duodenum (P = .006), jejunum (P = .029), and ileum (P = .140) in group 1 compared with group 2. Significant distention was also evident by comparing the products of the widest cross-sectional diameters in duodenum (P = .143), jejunum (P < .001), and ileum (P < .001). Group 1 also demonstrated significantly better visualization of mural features in the duodenum (P = .003), jejunum (P = .024), and ileum (P = .01) and a trend toward better visualization of mural features in the stomach (P = .092).

Conclusion: Oral administration of Volumen provided excellent distention and excellent visualization of mural features in the gastrointestinal tract.

© RSNA, 2005







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2005 by the Radiological Society of North America.